NASDAQ · Biotechnology

VCYT (VCYT) Stock

$55.71 +0.11% NASDAQ: VCYT Healthcare

Valuation

MetricValue
Price$55.71
Market Cap$4.45B
P/E Ratio50.61
P/B Ratio2.53
P/S Ratio6.10
EPS (TTM)$0.82
52-Week High$60.66
52-Week Low$22.61
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE5.04%
ROA4.69%
ROCE5.65%
Gross Margin14.31%
Operating Margin14.31%
Net Margin16.25%
Debt/Equity0.03
Current Ratio8.13

Annual Financials (USD)

Metric20212022202320242025
Revenue$220.0M$297.0M$361.0M$446.0M$517.0M
Operating Profit$-82.0M$-41.0M$-86.0M$16.0M$74.0M
Net Profit$-76.0M$-37.0M$-74.0M$24.0M$66.0M
EPS$-1.11$-0.51$-1.02$0.31$0.82
Op Margin-37.3%-13.8%-23.8%3.6%14.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.2B$1.2B$1.1B$1.3B$1.4B
Total Liabilities$91.0M$81.0M$71.0M$124.0M$96.0M
Cash$173.0M$154.0M$216.0M$239.0M$363.0M
Borrowings$19.0M$15.0M$13.0M$51.0M$40.0M

Latest News

What to Know About This $197,000 Veracyte Insider Sale After a 120% Stock Rally Motley Fool · Jun 27, 2026 This Top Stock Has Surged. CEO Explains Key To Veracyte's Success. Investor's Business Daily · Jun 18, 2026 Dow Jones Futures: Techs Rebound, SpaceX Rises Despite Trump's Iran Threat; Warsh's Fed Debut Due Investor's Business Daily · Jun 17, 2026 Here's How Much a $1000 Investment in Veracyte Made 10 Years Ago Would Be Worth Today Zacks · Jun 10, 2026 Veracyte Insider Sold Shares Worth $6,919,585, According to a Recent SEC Filing MT Newswires · Jun 5, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-32.0M$8.0M$44.0M$75.0M$136.0M
Investing Cash Flow$-745.0M$-38.0M$5.0M$-68.0M$-19.0M
Financing Cash Flow$2.0M$5.0M$3.0M$-15.0M$-18.0M
Net Cash Flow$-176.0M$-19.0M$62.0M$23.0M$124.0M
Free Cash Flow$-37.0M$-1.0M$34.0M$64.0M$127.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA31.46
FCF Yield4.68%
Quick Ratio9.31
Interest Coverage—
Return 1Y158.49%
Return 3Y108.29%
Return 5Y55.55%

Ownership

Insiders Held0.54%
Institutions Held112.66%
Institutions Float Held113.27%
Institutional HolderSharesReport Date
Blackrock Inc.13,172,6182026-03-31
FMR, LLC7,763,8492026-03-31
Artisan Partners Limited Partnership5,496,3702026-03-31
State Street Corporation5,043,5902026-03-31
Vanguard Portfolio Management LLC4,444,7302026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADPT $24.93 +5.64% -69.84 $3.99B 0.00%
APLSApellis Pharmaceuticals, Inc. $41.03 +0.00% 38.37 $5.25B 0.00%
FOLDAmicus Therapeutics Inc $14.49 +0.00% -161.00 $4.55B 0.00%
IDYA $36.02 -2.05% -22.12 $3.42B 0.00%
IRON $73.86 -1.01% -9.08 $2.82B 0.00%

About VCYT

VCYT stock trades at $55.71 with a market capitalization of $4.45B. The stock is valued at a price-to-earnings (P/E) ratio of 50.61, price-to-book of 2.53, price-to-sales of 6.10. Over the past 52 weeks the stock has ranged between $22.61 and $60.66, and currently trades 8.2% below its 52-week high.

On profitability, VCYT generates a return on equity (ROE) of 5.04%, return on capital employed of 5.65%, an operating margin of 14.31%, a net profit margin of 16.25%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides